| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 05/04/2005 | EP1526895A2 Methods for treating carbonic anhydrase mediated disorders |
| 05/04/2005 | EP1526869A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 05/04/2005 | EP1446399B1 Piperazine derivatives having sst1 antagonistic activity |
| 05/04/2005 | EP1411881B1 5ht2c receptor modulators |
| 05/04/2005 | EP1364212A4 Three hybrid assay system |
| 05/04/2005 | EP1362048B1 Triazolo compounds as mmp inhibitors |
| 05/04/2005 | EP1317448B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2005 | EP1296984B1 Pharmaceutical composition comprising a farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer |
| 05/04/2005 | EP1180126B1 Subphthalocyanine colorants, ink compositions and methods of making the same |
| 05/04/2005 | EP1152762B1 Use of desoxypeganine in the treatment of alzheimer's dementia |
| 05/04/2005 | EP1109812B1 Pyrrolobenzodiazepines |
| 05/04/2005 | CN1612880A Process for producing phenserine and its analog |
| 05/04/2005 | CN1612860A Compositions, methods and kits pertaining to luminescent compounds |
| 05/04/2005 | CN1612736A Imidazo (4, 3-e)-1, 2, 4-triazolo(1, 5-c) pyrimidines as adenosine A2A receptor antagonists |
| 05/04/2005 | CN1612105A Processing instructions |
| 05/04/2005 | CN1611501A Improved method for preparing metal-free phthalocyanin compound |
| 05/04/2005 | CN1611500A 3-aryl-Beta-carboline-1-ketone compound, and its preparing method and use |
| 05/04/2005 | CN1199973C Substituted carboblnie metal complex application |
| 05/03/2005 | US6888004 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 05/03/2005 | US6887997 Tricyclic analogues of guanosine, a nucleobase for treating tumor |
| 05/03/2005 | US6887996 Compounds and their use |
| 05/03/2005 | US6887870 Useful as antianginal and cardioprotective agents; for therapy and prophylaxis of angina pectoris, cardiac dysfunction, myocardial necrosis, and arrhythmia |
| 05/03/2005 | CA2347950C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 05/03/2005 | CA2236208C Substituted sulphonylamino (thio)carbonyl compounds as herbicides |
| 05/03/2005 | CA2201477C New pyrimidone derivatives with antifungal activity |
| 04/28/2005 | WO2005037954A1 New organic compound and organic light emitting device using the same |
| 04/28/2005 | WO2005037928A2 Compounds for dual photodiagnosis and therapy |
| 04/28/2005 | WO2005037843A1 Compositions useful as inhibitors of protein kinases |
| 04/28/2005 | WO2005037838A1 Heteroaryl-substituted pyrrolo-triazine compounds useful as kinase inhibitors |
| 04/28/2005 | WO2005037837A1 SUBSTITUTED 2-AMINO-[1,2,4]TRIAZOLO[1,5-a]PYRIMIDINE DERIVATIVE AND USE THEREOF |
| 04/28/2005 | WO2005037836A2 Imidazo ‘1, 5 - a ! pyrazine tyrosine kinase inhibitors |
| 04/28/2005 | WO2005037825A2 Protein kinase inhibitors |
| 04/28/2005 | WO2005037783A2 Use of tricyclic compounds as glycine transport inhibitors |
| 04/28/2005 | WO2005037257A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | WO2005037214A2 Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication |
| 04/28/2005 | WO2005021495A3 Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones |
| 04/28/2005 | WO2005011581A3 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 04/28/2005 | WO2005005398A3 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| 04/28/2005 | WO2005002293A3 Cox-2-targeted imaging agents |
| 04/28/2005 | WO2004099213A3 Pyrrolo (1,2-b) pyridazine compounds and their use as crf-1 receptor antagonists |
| 04/28/2005 | WO2004085387A3 Water-soluble mono-pegylated tetrapyrrole derivatives for photodynamic therapy and method of production |
| 04/28/2005 | US20050090667 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 04/28/2005 | US20050090665 Such as 5,7-dimethyl-6-phenyl-1,2,4-triazolo[1,5a]pyrimidine |
| 04/28/2005 | US20050090543 Method for the preparation of tetrahydrobenzothiepines |
| 04/28/2005 | US20050090533 Treating schizophrenia by administering an N-(2-aminopyridin-5-yl)amino-phenylisobutyramide, e.g., N-[6-(2-acetylamino-ethylamino)-4-(2-chloro-phenyl)-pyridin-3-yl]-2-(3,5-bis-trifluoromethyl-phenyl)-N-methyl-isobutyramide |
| 04/28/2005 | US20050090513 Compounds specific to adenosine a1 and a3 receptors and uses thereof |
| 04/28/2005 | US20050090508 6-[(Substituted)phenyl]triazolopyrimidines as anticancer agents |
| 04/28/2005 | US20050090507 Administered singly or in combination with a second antineoplastic agent; cyclin-dependent kinase inhibitors, antiproliferative agents; coupling and cyclization of a 1-aminopyridazinium salt with a 2-alkylthio-4-alkynyl pyrimidine compound |
| 04/28/2005 | US20050090499 Oral or injectable dosage forms; antiproliferative, anticarcinogenic, and antiinflammatory agents; ATP hydrolysis inhibition |
| 04/28/2005 | US20050090498 3-Quinolin-2(1h)-ylideneindolin-2-one derivative |
| 04/28/2005 | US20050090497 Novel ester or amide derivatives |
| 04/28/2005 | US20050090492 Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine |
| 04/28/2005 | US20050090483 Purine derivatives as kinase inhibitors |
| 04/28/2005 | US20050090472 Xanthine oxidase inhibitors |
| 04/28/2005 | US20050090471 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 04/28/2005 | US20050089479 Delivery of sedative-hypnotics through an inhalation route |
| 04/28/2005 | CA2542723A1 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | CA2542694A1 Compounds for dual photodiagnosis and therapy |
| 04/28/2005 | CA2542290A1 Substituted 2-amino-[1,2,4]triazolo[1,5-a]pyrimidine derivative and use thereof |
| 04/28/2005 | CA2542113A1 Compositions useful as inhibitors of protein kinases |
| 04/28/2005 | CA2542076A1 Substituted tricyclic compounds as protein kinase inhibitors |
| 04/27/2005 | EP1526136A1 Polymorphs of zaleplon and methods for the preparation thereof |
| 04/27/2005 | EP1525205A2 Novel substituted pyrazolo( 1,5-a /i ]-1,3,5-triazine derivatives and their analogues, pharmaceutical compositions containing same, use thereof as medicine and methods for preparing same |
| 04/27/2005 | EP1524974A2 Transcription factor modulating compounds and methods of use thereof |
| 04/27/2005 | EP1461316A4 Synthesis of 2-cyanoziridine-1-carboxamide |
| 04/27/2005 | EP1423110A4 Cbi analogues of cc-1065 and the duocarmycins |
| 04/27/2005 | EP1406905A4 Water- and organic-soluble cucurbituril derivatives, their preparation methods, their separation methods and uses |
| 04/27/2005 | EP1325010B1 Substituted 3.4-dihydro-pyrimido [1,2-a]pyrimidines and 3.4-dihydropyrazino [1,2-a]pyrimidines |
| 04/27/2005 | EP1144411B1 Antihistaminic spiro compounds |
| 04/27/2005 | CN1610683A Pyrimidotriazines as phosphatase inhibitors |
| 04/27/2005 | CN1610682A Polymorphs of zaleplon and methods for the preparation thereof |
| 04/27/2005 | CN1610666A Benzamidine derivative |
| 04/27/2005 | CN1609107A Purification of high-purity triethylenediamine (TEDA) by distillation |
| 04/27/2005 | CN1609106A Prepn process of imide derivative |
| 04/27/2005 | CN1609105A 1-methylolimidazole [1, 2-alpha] quinoxaline compound and its application |
| 04/27/2005 | CN1198826C Process for synthesizing phthalooyanine by microwave method |
| 04/27/2005 | CN1198825C 8-pheyl-6,9-dihydro-[1,2,4]triazolo[3,4-i] purin-5-one derivatives |
| 04/27/2005 | CN1198824C Polymorphs of N-methyl-N-(3-3-{2-thienylcarbonyl]-pyrazol -[1,5-alpha]-pyrimidin-7-yl}phenyl)a cetamide and compositions and methods related thereton |
| 04/27/2005 | CN1198573C Oxidation dyeing composition for keratinous fibres and dyeing method using same |
| 04/26/2005 | US6884888 Reacting mixture of N-(3-(3-(dimethylamino)-1-oxo-2-propenyl)phenyl)-N-ethylacetamide and 3-amino-4-cyanopyrazole in a liquid reaction medium; recovering |
| 04/26/2005 | US6884806 Treatment of rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration, tumor metastasis, periodontal disease, bone disease |
| 04/26/2005 | US6884477 Electroluminescence device using liquid crystal compound |
| 04/26/2005 | US6884408 Delivery of diphenhydramine through an inhalation route |
| 04/21/2005 | WO2005035535A1 Certain substituted spirocyclic lactams and use thereof as pharmaceuticals |
| 04/21/2005 | WO2005035533A1 Modulators of serotonin receptors |
| 04/21/2005 | WO2005035532A1 Substituted 2h-[1,2,4]triazolo[4,3-a]pyrazines as gsk-3 inhibitors |
| 04/21/2005 | WO2005035516A1 Novel fused heterocyclic compound and use thereof |
| 04/21/2005 | WO2005035498A1 Use of nitrogenous bicyclic compound as feeding control agent |
| 04/21/2005 | WO2005035442A1 Method of fullerene separation and complex containing fullerene |
| 04/21/2005 | WO2005034856A2 Targeted drug-formaldehyde conjugates and methods of making and using the same |
| 04/21/2005 | WO2005034838A2 Protease inhibitors |
| 04/21/2005 | WO2005034837A2 7H-IMIDAZO [1,2-α] PYRAZIN-8-ONE COMPOUNDS AS ION CHANNEL MODULATORS |
| 04/21/2005 | WO2005023807A3 4 - heterobicyclyamino - substituted quinazolines and analogues therof as capsaicin - antagonists |
| 04/21/2005 | WO2005013907A3 Pyrrolo[1,2-b]pyridazine derivatives |
| 04/21/2005 | WO2005004801A3 Indole, azaindole and related heterocyclic n-substituted piperazine derivatives |
| 04/21/2005 | WO2004111047A3 Cycloalkanepyrrolopyridines as dp receptor antagonists |
| 04/21/2005 | WO2004026863A8 Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors |
| 04/21/2005 | WO2002057425A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 04/21/2005 | US20050085531 Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 04/21/2005 | US20050085490 Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents |